Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Mohit Bansal is an analyst at Wells Fargo. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/28/2024
| Buy Now | Get Alert | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 06/27/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 39.68% | $110 → $115 | Maintains | Overweight | Get Alert |
| 06/24/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | 18.34% | $540 → $555 | Maintains | Overweight | Get Alert |
| 06/07/2024 | HALO | Buy Now | Halozyme Therapeutics | $52.36 | 10.77% | $48 → $58 | Maintains | Overweight | Get Alert |
| 04/25/2024 | BMRN | Buy Now | Biomarin Pharmaceutical | $82.33 | 33.61% | $100 → $110 | Maintains | Overweight | Get Alert |
| 04/24/2024 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | 23.48% | $140 → $170 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/18/2024 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 24.94% | $51 → $52 | Maintains | Equal-Weight | Get Alert |
| 03/27/2024 | MRK | Buy Now | Merck & Co | $125.00 | 8% | $130 → $135 | Maintains | Equal-Weight | Get Alert |
| 03/04/2024 | GILD | Buy Now | Gilead Sciences | $68.65 | 13.62% | $84 → $78 | Maintains | Equal-Weight | Get Alert |
| 03/01/2024 | IRWD | Buy Now | Ironwood Pharmaceuticals | $6.52 | 114.72% | $20 → $14 | Maintains | Overweight | Get Alert |
| 02/16/2024 | TVTX | Buy Now | Travere Therapeutics | $8.22 | 9.49% | $8 → $9 | Maintains | Equal-Weight | Get Alert |
| 02/14/2024 | BIIB | Buy Now | Biogen | $231.82 | 3.53% | $315 → $240 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/08/2024 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | 1.69% | $127 → $140 | Maintains | Equal-Weight | Get Alert |
| 02/07/2024 | LLY | Buy Now | Eli Lilly | $906.04 | -8.94% | $700 → $825 | Maintains | Overweight | Get Alert |
| 02/07/2024 | GILD | Buy Now | Gilead Sciences | $68.65 | 22.36% | $90 → $84 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | LLY | Buy Now | Eli Lilly | $906.04 | -8.94% | $700 → $825 | Maintains | Overweight | Get Alert |
| 02/06/2024 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 22.54% | $58 → $51 | Maintains | Equal-Weight | Get Alert |
| 02/06/2024 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | 15.14% | $500 → $540 | Maintains | Overweight | Get Alert |
| 02/02/2024 | MRK | Buy Now | Merck & Co | $125.00 | 4% | $125 → $130 | Maintains | Equal-Weight | Get Alert |
| 01/24/2024 | LLY | Buy Now | Eli Lilly | $906.04 | -22.74% | $650 → $700 | Maintains | Overweight | Get Alert |
| 12/14/2023 | IRWD | Buy Now | Ironwood Pharmaceuticals | $6.52 | 206.75% | → $20 | Initiates | → Overweight | Get Alert |
| 12/13/2023 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -7.75% | $110 → $127 | Maintains | Equal-Weight | Get Alert |
| 11/09/2023 | BIIB | Buy Now | Biogen | $231.82 | 57.45% | $343 → $365 | Maintains | Overweight | Get Alert |
| 10/17/2023 | PFE | Buy Now | Pfizer | $27.97 | 25.13% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
| 10/16/2023 | PFE | Buy Now | Pfizer | $27.97 | 25.13% | $39 → $35 | Maintains | Equal-Weight | Get Alert |
| 10/09/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -28.26% | $615 → $650 | Maintains | Overweight | Get Alert |
| 09/22/2023 | TVTX | Buy Now | Travere Therapeutics | $8.22 | -2.68% | $24 → $8 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 08/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -6.76% | $875 → $980 | Maintains | Overweight | Get Alert |
| 08/08/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -32.12% | $500 → $615 | Maintains | Overweight | Get Alert |
| 08/07/2023 | BIIB | Buy Now | Biogen | $231.82 | 47.96% | $350 → $343 | Maintains | Overweight | Get Alert |
| 08/02/2023 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | -9.38% | $410 → $425 | Maintains | Overweight | Get Alert |
| 08/01/2023 | KDNY | Buy Now | Chinook Therapeutics | — | — | $30 → $40 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 07/28/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 56.17% | $78 → $65 | Maintains | Equal-Weight | Get Alert |
| 05/26/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -44.81% | $440 → $500 | Maintains | Overweight | Get Alert |
| 05/04/2023 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -20.1% | $115 → $110 | Maintains | Equal-Weight | Get Alert |
| 05/04/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.89 | -26.63% | → $30 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 05/02/2023 | TVTX | Buy Now | Travere Therapeutics | $8.22 | 191.97% | $28 → $24 | Maintains | Overweight | Get Alert |
| 04/28/2023 | ABBV | Buy Now | AbbVie | $170.75 | 14.2% | $200 → $195 | Maintains | Overweight | Get Alert |
| 04/28/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -51.44% | $375 → $440 | Maintains | Overweight | Get Alert |
| 03/24/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -12.94% | $860 → $915 | Maintains | Overweight | Get Alert |
| 03/17/2023 | PFE | Buy Now | Pfizer | $27.97 | 57.31% | $50 → $44 | Maintains | Equal-Weight | Get Alert |
| 03/17/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.36 | -8.33% | $55 → $48 | Maintains | Overweight | Get Alert |
| 03/16/2023 | HALO | Buy Now | Halozyme Therapeutics | $52.36 | 5.04% | $65 → $55 | Maintains | Overweight | Get Alert |
| 03/13/2023 | MRK | Buy Now | Merck & Co | $125.00 | -8% | $120 → $115 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 03/13/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -58.61% | $360 → $375 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/13/2023 | AMGN | Buy Now | Amgen | $312.45 | -15.19% | $275 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 03/07/2023 | MLYS | Buy Now | Mineralys Therapeutics | $11.70 | 130.77% | → $27 | Initiates | → Overweight | Get Alert |
| 02/23/2023 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.89 | -26.63% | $38 → $30 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 02/21/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -18.18% | $800 → $860 | Maintains | Overweight | Get Alert |
| 02/17/2023 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -18.18% | $800 → $860 | Maintains | Overweight | Get Alert |
| 02/07/2023 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -16.47% | $120 → $115 | Maintains | Equal-Weight | Get Alert |
| 02/03/2023 | MRK | Buy Now | Merck & Co | $125.00 | -4% | $125 → $120 | Maintains | Overweight | Get Alert |
| 02/03/2023 | LLY | Buy Now | Eli Lilly | $906.04 | -60.27% | $375 → $360 | Maintains | Equal-Weight | Get Alert |
| 02/01/2023 | AMGN | Buy Now | Amgen | $312.45 | -11.99% | $285 → $275 | Maintains | Equal-Weight | Get Alert |
| 01/17/2023 | PFE | Buy Now | Pfizer | $27.97 | 78.76% | $54 → $50 | Downgrade | Overweight → Equal-Weight | Get Alert |
| 01/03/2023 | MRK | Buy Now | Merck & Co | $125.00 | — | $110 → $125 | Maintains | Overweight | Get Alert |
| 01/03/2023 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 87.41% | $70 → $78 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | GILD | Buy Now | Gilead Sciences | $68.65 | 31.1% | $75 → $90 | Maintains | Equal-Weight | Get Alert |
| 01/03/2023 | AMGN | Buy Now | Amgen | $312.45 | -8.79% | $250 → $285 | Maintains | Equal-Weight | Get Alert |
| 12/08/2022 | LLY | Buy Now | Eli Lilly | $906.04 | -58.61% | $365 → $375 | Maintains | Equal-Weight | Get Alert |
| 11/28/2022 | XENE | Buy Now | Xenon Pharmaceuticals | $38.99 | 28.24% | → $50 | Initiates | → Overweight | Get Alert |
| 11/28/2022 | HALO | Buy Now | Halozyme Therapeutics | $52.36 | 24.14% | → $65 | Initiates | → Overweight | Get Alert |
| 11/02/2022 | PFE | Buy Now | Pfizer | $27.97 | 93.06% | $55 → $54 | Maintains | Overweight | Get Alert |
| 11/02/2022 | LLY | Buy Now | Eli Lilly | $906.04 | -59.71% | $305 → $365 | Maintains | Equal-Weight | Get Alert |
| 11/02/2022 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -12.84% | $110 → $120 | Maintains | Equal-Weight | Get Alert |
| 10/28/2022 | MRK | Buy Now | Merck & Co | $125.00 | -12% | $105 → $110 | Maintains | Overweight | Get Alert |
| 10/28/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | -28.57% | $305 → $335 | Maintains | Overweight | Get Alert |
| 10/28/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | 9.25% | $74 → $75 | Maintains | Equal-Weight | Get Alert |
| 09/28/2022 | BIIB | Buy Now | Biogen | $231.82 | 50.98% | $265 → $350 | Maintains | Overweight | Get Alert |
| 09/26/2022 | NBIX | Buy Now | Neurocrine Biosciences | $137.67 | -20.1% | → $110 | Initiates | → Equal-Weight | Get Alert |
| 09/26/2022 | CERE | Buy Now | Cerevel Therapeutics Hldg | $40.89 | -7.07% | → $38 | Initiates | → Overweight | Get Alert |
| 09/13/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | 7.79% | $63 → $74 | Maintains | Equal-Weight | Get Alert |
| 09/12/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -23.88% | $735 → $800 | Maintains | Overweight | Get Alert |
| 06/03/2022 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -30.07% | $750 → $735 | Maintains | Overweight | Get Alert |
| 05/17/2022 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 68.19% | $65 → $70 | Maintains | Equal-Weight | Get Alert |
| 05/06/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | -34.97% | $300 → $305 | Maintains | Overweight | Get Alert |
| 05/04/2022 | PFE | Buy Now | Pfizer | $27.97 | 96.64% | $60 → $55 | Maintains | Overweight | Get Alert |
| 05/02/2022 | ABBV | Buy Now | AbbVie | $170.75 | 17.13% | $165 → $200 | Maintains | Overweight | Get Alert |
| 04/29/2022 | MRK | Buy Now | Merck & Co | $125.00 | -16% | $90 → $105 | Maintains | Overweight | Get Alert |
| 04/29/2022 | LLY | Buy Now | Eli Lilly | $906.04 | -66.34% | $280 → $305 | Maintains | Equal-Weight | Get Alert |
| 04/18/2022 | BIIB | Buy Now | Biogen | $231.82 | 14.31% | $235 → $265 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 04/05/2022 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | -36.03% | $270 → $300 | Maintains | Overweight | Get Alert |
| 03/22/2022 | GILD | Buy Now | Gilead Sciences | $68.65 | -8.23% | $70 → $63 | Maintains | Equal-Weight | Get Alert |
| 03/02/2022 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 56.17% | $60 → $65 | Maintains | Equal-Weight | Get Alert |
| 02/09/2022 | AMGN | Buy Now | Amgen | $312.45 | -19.99% | $210 → $250 | Maintains | Equal-Weight | Get Alert |
| 02/04/2022 | BIIB | Buy Now | Biogen | $231.82 | 1.37% | $284 → $235 | Maintains | Equal-Weight | Get Alert |
| 01/07/2022 | PFE | Buy Now | Pfizer | $27.97 | 132.39% | $60 → $65 | Maintains | Overweight | Get Alert |
| 01/04/2022 | LLY | Buy Now | Eli Lilly | $906.04 | -69.1% | $270 → $280 | Maintains | Equal-Weight | Get Alert |
| 12/09/2021 | ABBV | Buy Now | AbbVie | $170.75 | -3.37% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | REGN | Buy Now | Regeneron Pharmaceuticals | $1.05K | -28.64% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | VRTX | Buy Now | Vertex Pharmaceuticals | $469.00 | -42.43% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | MRK | Buy Now | Merck & Co | $125.00 | -28% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | BIIB | Buy Now | Biogen | $231.82 | 7.84% | — | Initiates | → Equal-Weight | Get Alert |
| 12/09/2021 | PFE | Buy Now | Pfizer | $27.97 | 114.52% | — | Initiates | → Overweight | Get Alert |
| 12/09/2021 | BMY | Buy Now | Bristol-Myers Squibb | $41.62 | 39.36% | — | Initiates | → Equal-Weight | Get Alert |
| 12/09/2021 | AMGN | Buy Now | Amgen | $312.45 | -32.79% | — | Initiates | → Equal-Weight | Get Alert |
| 12/09/2021 | GILD | Buy Now | Gilead Sciences | $68.65 | 4.88% | — | Initiates | → Equal-Weight | Get Alert |
| 12/09/2021 | LLY | Buy Now | Eli Lilly | $906.04 | -70.2% | — | Initiates | → Equal-Weight | Get Alert |
